| Unique ID issued by UMIN | UMIN000035531 |
|---|---|
| Receipt number | R000040481 |
| Scientific Title | Assessment of ketamine effect on cancer pain and depression |
| Date of disclosure of the study information | 2019/02/01 |
| Last modified on | 2020/03/26 15:48:43 |
Assessment of ketamine effect on cancer pain and depression
cancer and depression
Assessment of ketamine effect on cancer pain and depression
cancer and depression
| Japan |
cancer pain
| Anesthesiology |
Malignancy
NO
To assess the effect of ketamine on cancer pain and depression
Efficacy
relationship between numerical rating scale and state of depression
assessment of biomarkers
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
| Medicine |
Injection intravenous of ketamine 0.05 mg/kg and midazolam 0.04 mg/kg for 40 min
| 20 | years-old | <= |
| 65 | years-old | >= |
Male and Female
a patient who has both cancer pain and depression
a patient who has allergy to ketamine and past history of high intraocular or intracranial pressure
30
| 1st name | |
| Middle name | |
| Last name | Takashi Kudo |
Hirosaki University Hospital
department of anesthesiology
53 Honcho, Hirosaki city, Aomori, Japan
0172335111
takf5@hirosaki-u.ac.jp
| 1st name | |
| Middle name | |
| Last name | Takashi Kudo |
Hirosaki University Hospital
department of anesthesiology
53 Honcho, Hirosaki city, Aomori, Japan
0172335111
takf5@hirosaki-u.ac.jp
Hirosaki University Hospital
Hirosaki University Hospital
Self funding
NO
| 2019 | Year | 02 | Month | 01 | Day |
Unpublished
Preinitiation
| 2018 | Year | 12 | Month | 01 | Day |
| 2019 | Year | 02 | Month | 01 | Day |
| 2020 | Year | 12 | Month | 31 | Day |
| 2019 | Year | 01 | Month | 12 | Day |
| 2020 | Year | 03 | Month | 26 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040481